Here are five insights:
1. Hospitals are no longer falling prey to the device company strategy of making slight improvements in existing devices and increasing prices.
2. The device companies can also no longer depend on physician loyalty, as many physicians work for hospitals and don’t have much say.
3. Competition may also drive down prices, as hospitals feel pressured to cut costs.
4. Some medical device companies are coping with the shift in trends by buying out emerging companies with more costly innovative products.
5. Since 2010, global average sale prices for common cardiac and orthopedic devices have decreased by about 4 percent, according to GlobalData data.
More articles on devices:
Orthopedic, spine device company M&A & partnerships: 9 recent deals
Dr. David Greenwald 1st to successfully implant VerteLP Lateral Lumber Cage: 4 key notes
Brian Ennis becomes president of Implanet America: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
